Remove 2016 Remove Blogging Remove Layoffs
article thumbnail

Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More

Xconomy

. —Funding rounds: Cambridge-based Mersana Therapeutics closed a $33 million Series C round with the aim of testing its first drug, an antibody-drug conjugate for breast cancer called XMT-1522… Rockefeller University spinout Rgenix’s $33 million financing was the second largest for a privately held Manhattan biotech this year.

News 55
article thumbnail

Xconomy’s Top Innovation Stories of the Half Year

Xconomy

Here we are at the midpoint of 2016 already. Layoffs Reflect New Turbulence at High-Flying 3D Robotics. Time to look back on the past six months—and some of the top stories of the year so far. Amid Leadership Changes, NY Biotech Braces for Its Pivotal Moment. AgTech Accelerator Aims to Sway Agriculture Investment Trends.

article thumbnail

Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More

Xconomy

—The 2016 Nobel Prize for Physiology or Medicine went to Yoshinori Ohsumi of the Tokyo Institute of Technology. —Merrimack Pharmaceuticals (NASDAQ: MACK ) announced layoffs of 22 percent of its staff and the resignation of CEO Robert Mulroy. . —The U.S. THE ENVELOPE, PLEASE. for their work on molecular machines. .